- Home
- MLYS vs AMBC Comparison
MLYS vs AMBC Comparison
Compare MLYS & AMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- AMBC
- Stock Information
- Founded
- MLYS 2019
- AMBC 1971
- Country
- MLYS United States
- AMBC United States
- Employees
- MLYS N/A
- AMBC N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- AMBC Property-Casualty Insurers
- Sector
- MLYS Health Care
- AMBC Finance
- Exchange
- MLYS Nasdaq
- AMBC Nasdaq
- Market Cap
- MLYS 1.0B
- AMBC 411.3M
- IPO Year
- MLYS 2023
- AMBC 1991
- Fundamental
- Price
- MLYS $14.63
- AMBC $7.27
- Analyst Decision
- MLYS Strong Buy
- AMBC Strong Buy
- Analyst Count
- MLYS 4
- AMBC 2
- Target Price
- MLYS $27.00
- AMBC $12.50
- AVG Volume (30 Days)
- MLYS 885.1K
- AMBC 912.6K
- Earning Date
- MLYS 08-12-2025
- AMBC 08-04-2025
- Dividend Yield
- MLYS N/A
- AMBC N/A
- EPS Growth
- MLYS N/A
- AMBC N/A
- EPS
- MLYS N/A
- AMBC N/A
- Revenue
- MLYS N/A
- AMBC $253,912,000.00
- Revenue This Year
- MLYS N/A
- AMBC N/A
- Revenue Next Year
- MLYS N/A
- AMBC $17.41
- P/E Ratio
- MLYS N/A
- AMBC N/A
- Revenue Growth
- MLYS N/A
- AMBC 125.08
- 52 Week Low
- MLYS $8.24
- AMBC $5.99
- 52 Week High
- MLYS $18.38
- AMBC $13.64
- Technical
- Relative Strength Index (RSI)
- MLYS 54.08
- AMBC 49.50
- Support Level
- MLYS $14.07
- AMBC $6.87
- Resistance Level
- MLYS $14.70
- AMBC $8.07
- Average True Range (ATR)
- MLYS 0.69
- AMBC 0.29
- MACD
- MLYS 0.15
- AMBC 0.03
- Stochastic Oscillator
- MLYS 80.69
- AMBC 28.69
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.